DCIS linked to higher breast cancer mortality, despite treatment

Reuters Health - 24/09/2020 - The risk of dying from breast cancer is about three times higher in women with carcinoma in situ (DCIS) than in the general population, even after treatment focused on preventing invasion, an observational study suggests. The study complements the group's earlier work (https://bit.ly/3i2lpV8) showing that 3% of women who are diagnosed with DCIS succumb to breast cancer within 20 years, coauthor Dr. Steven Narod of Women's College Research Institute and the University of Toronto told Reuters Health by email. "It is generally accepted and communicated to patients that DCIS is not cancer, but a pre-cancer, and that DCIS predisposes to invasive cancer," he said. "Invasive cancer is usually in the form of local recurrence in the same breast, but can be distant recurrence in the lung, liver, brain, bone or lymph nodes." Preventing local invasion "is a valid ...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 24 September, 202029 September, 2020